Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.

Hermos JA, Young MM, Fonda JR, Gagnon DR, Fiore LD, Lawler EV.

Clin Infect Dis. 2012 Jan 1;54(1):33-42. doi: 10.1093/cid/cir767. Epub 2011 Nov 18.

PMID:
22100573
2.

Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.

Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR.

Am J Med. 2010 Jan;123(1):47-53. doi: 10.1016/j.amjmed.2009.05.032.

PMID:
20102991
3.

Proton-pump inhibitor use and the risk for community-acquired pneumonia.

Sarkar M, Hennessy S, Yang YX.

Ann Intern Med. 2008 Sep 16;149(6):391-8.

PMID:
18794558
4.

Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.

Giuliano C, Wilhelm SM, Kale-Pradhan PB.

Expert Rev Clin Pharmacol. 2012 May;5(3):337-44. doi: 10.1586/ecp.12.20.

PMID:
22697595
5.

Microbial evaluation of proton-pump inhibitors and the risk of pneumonia.

Meijvis SC, Cornips MC, Voorn GP, Souverein PC, Endeman H, Biesma DH, Leufkens HG, van de Garde EM.

Eur Respir J. 2011 Nov;38(5):1165-72. doi: 10.1183/09031936.00020811. Epub 2011 Apr 8.

6.

Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia.

Jena AB, Sun E, Goldman DP.

J Gen Intern Med. 2013 Feb;28(2):223-30. doi: 10.1007/s11606-012-2211-5. Epub 2012 Sep 7.

7.

Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.

de Jager CP, Wever PC, Gemen EF, van Oijen MG, van Gageldonk-Lafeber AB, Siersema PD, Kusters GC, Laheij RJ.

Aliment Pharmacol Ther. 2012 Nov;36(10):941-9. doi: 10.1111/apt.12069. Epub 2012 Oct 3.

8.

Proton pump inhibitors and risk for recurrent Clostridium difficile infection.

Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA.

Arch Intern Med. 2010 May 10;170(9):772-8. doi: 10.1001/archinternmed.2010.73. Erratum in: Arch Intern Med. 2010 Jul 12;170(13):1100.

PMID:
20458084
9.

Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia.

Roughead EE, Ramsay EN, Pratt NL, Ryan P, Gilbert AL.

Med J Aust. 2009 Feb 2;190(3):114-6.

PMID:
19203305
10.

Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.

Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J.

Arch Intern Med. 2007 May 14;167(9):950-5.

PMID:
17502537
11.

Proton pump inhibitor discontinuation in long-term care.

Linsky A, Hermos JA, Lawler EV, Rudolph JL.

J Am Geriatr Soc. 2011 Sep;59(9):1658-64. doi: 10.1111/j.1532-5415.2011.03545.x. Epub 2011 Aug 24.

PMID:
21883102
12.

Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K.

Am J Gastroenterol. 2009 May;104(5):1130-4. doi: 10.1038/ajg.2009.80. Epub 2009 Mar 31.

PMID:
19337238
13.

Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.

Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TA.

PLoS One. 2015 Jun 4;10(6):e0128004. doi: 10.1371/journal.pone.0128004. eCollection 2015. Review.

14.

Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Dublin S, Walker RL, Jackson ML, Nelson JC, Weiss NS, Jackson LA.

Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):792-802. doi: 10.1002/pds.1978.

15.

Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia.

de Groot MC, Klungel OH, Leufkens HG, van Dijk L, Grobbee DE, van de Garde EM.

Eur J Epidemiol. 2014 Oct;29(10):767-75. doi: 10.1007/s10654-014-9941-0. Epub 2014 Aug 26.

PMID:
25154551
16.

Pharmacotherapy and the risk for community-acquired pneumonia.

Gau JT, Acharya U, Khan S, Heh V, Mody L, Kao TC.

BMC Geriatr. 2010 Jul 6;10:45. doi: 10.1186/1471-2318-10-45.

17.

Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.

Oudit GY, Bakal JA, McAlister FA, Ezekowitz JA.

Eur J Heart Fail. 2011 Nov;13(11):1211-5. doi: 10.1093/eurjhf/hfr104. Epub 2011 Aug 10.

18.

Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.

Stevens V, Dumyati G, Brown J, Wijngaarden E.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1035-42. doi: 10.1002/pds.2198. Epub 2011 Aug 10.

PMID:
21833992
19.

Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.

Johnstone J, Nerenberg K, Loeb M.

Aliment Pharmacol Ther. 2010 Jun;31(11):1165-77. doi: 10.1111/j.1365-2036.2010.04284.x. Epub 2010 Mar 4.

20.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

Supplemental Content

Support Center